Mar 15 |
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
|
Mar 11 |
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
|
Mar 11 |
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
|
Feb 22 |
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
|
Jan 24 |
Avenue Therapeutics files to sell 33.08M shares of common stock for holders
|
Jan 16 |
Sidoti Events, LLC's Virtual January Micro-Cap Conference
|
Jan 5 |
Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds
|
Jan 5 |
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
|
Jan 4 |
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jan 4 |
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
|